Identification of an eight-m6A RNA methylation regulator prognostic signature of uterine corpus endometrial carcinoma based on bioinformatics analysis-Reference-Cited by-同舟云学术

Identification of an eight-m6A RNA methylation regulator prognostic signature of uterine corpus endometrial carcinoma based on bioinformatics analysis

Published:2021-12-10 Issue:49 Volume:100 Page:e27689
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Miao Chenyun,Fang Xiaojie,Chen Yun,Zhao Ying,Guo Qingge

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference35 articles.

1. New insights into endometrial cancer;Paleari;Cancers (Basel),2021

2. Targeting endometrial cancer stem cell activity with metformin is inhibited by patient-derived adipocyte-secreted factors;Kitson;Cancers,2019

3. Cancer statistics, 2020;Siegel;CA Cancer J Clin,2020

4. Clinical actionability of molecular targets in endometrial cancer;Urick;Nat Rev Cancer,2019

5. Molecular classification and emerging targeted therapy in endometrial cancer;Yen;Int J Gynecol Pathol,2020

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overexpression of zinc finger DHHC-type containing 1 is associated with poor prognosis and cancer cell growth and metastasis in uterine corpus endometrial carcinoma;Aging;2024-06-06

2. Unraveling IGFBP3-mediated m6A modification in fracture healing;Pathology - Research and Practice;2024-03

3. Identifying the Role of Disulfidptosis in Endometrial Cancer via Machine Learning Methods;BioMedInformatics;2023-10-13

4. Shining a spotlight on m6A and the vital role of RNA modification in endometrial cancer: a review;Frontiers in Genetics;2023-10-11

5. Computational approaches for discovering significant microRNAs, microRNA-mRNA regulatory pathways, and therapeutic protein targets in endometrial cancer;Frontiers in Genetics;2023-01-10